Skingenix, USA joins Pasadena Bio Collaborative

Skingenix, USA has joined the Pasadena Bio Collaborative Incubator. Skingenix, USA specializes in the research and development of multi-compound products for dermal regeneration. As an innovative and mission-driven company, Skingenix pursues a standard of excellence in the regenerative medical industry with an emphasis on developing organ in situ regenerative products for improving human health and quality of life. The Company has completed a Phase II randomized and controlled multi-center clinical study to assess the safety and efficacy of their investigational product in patients with Diabetic Foot Ulcers in the USA and currently engaged in further development of their investigational product (MW-III).